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Abstract
In locations with a high rate of tuberculosis (TB) and HIV infection, there are a number of
strategies to prevent negative outcomes such as opportunistic infections, hospitalizations
and death, and this article investigates risk factors for the occurrence of hospitalization and
death in cases of TB/HIV co-infection in the south of Brazil. The data are taken from a popu-
lation-based retrospective cohort study on cases of TB/HIV co-infection from 2009 to 2013
in Porto Alegre, Brazil. Sociodemographic, epidemiological and clinical variables were ana-
lyzed. Relative risk (RR) estimates for hospitalization and death were determined by regres-
sion models. There were 2,419 co-infection cases, of which 1,527 (63.1%) corresponded to
hospitalizations, and 662 (27.4%) to death. The occurrence of hospitalization was associ-
ated with� 7 years of schooling (RR = 3.47, 95%CI: 1.97–6.29), 8–11 years of schooling
(RR = 2.56, 95%CI: 1.44–4.69), place of origin—district health authorities Northwest/
Humaita´/Navegantes/Ilhas (RR = 2.01, 95%CI: 1.44–2.82), type of entry into the surveil-
lance system as in cases of reentry after withdrawal (RR = 1,35, 95%CI: 1.07–1.70), closure
in surveillance as in withdrawal of treatment (RR = 1.47, 95%CI: 1.18–1.83) and multidrug-
resistant tuberculosis (RR = 3.94, 95%CI: 1.97–8.81). The occurrence of death was associ-
ated with age (RR = 1.07, 95%CI: 1,01–1,14),� 7 years of schooling (RR = 3.94, 95%CI:
2.26–7.09), 8–11 years of schooling (RR = 2.84, 95%CI: 1.61–5.16), place of origin—district
health authorities Baltazar (RR = 2.05, 95%CI: 1.48–2.86), type of entry in the surveillance
system as cases of re-entry after withdrawal (RR = 1.53, 95%CI: 1.22–1.91), relapse (RR =
1.33, 95%CI: 1.03–1.73). The occurrence of hospitalizations and deaths is high among co-
infected patients. Our estimation approach is important in order to identify, from the surveil-
lance data, the risk factors for hospitalization and death in co-infected patients, so that they
may receive more attention from the Brazilian national healthcare system.
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Introduction
Tuberculosis and human immunodeficiency virus (TB/HIV) co-infection is one of the most
complex clinical pictures in the field of public health [1–2]. The double burden of diseases
makes adherence to treatments difficult, a fact that is shown by high default rates, which con-
tribute to multidrug resistance [3–5]. Likewise, the social vulnerability of the patients may lead
to an increase in hospitalization rates and mortality [5–8]. Risk factors for hospitalization and
death in locations with a high incidence of co-infection such as Brazil have not been suffi-
ciently investigated.
Studies point out that the HIV/AIDS epidemic has contributed to the growth of the inci-
dence of tuberculosis [5,9]. People living with HIV/AIDS have a 3 to 15% annual risk of reacti-
vating latent tuberculosis infection, while the risk for the general population is only 0.1% [10].
Considering the period from 2000 to 2016, tuberculosis remains among the ten leading causes
of death in the world [11]. In Brazil, the estimated mortality rate due to co-infection was 0.9
per 100,000 inhabitants in 2016, which is higher than the rate in the Americas. Tuberculosis
was one of the world’s leading causes of death for people living with HIV in 2017, when deaths
related to HIV reached approximately 1.4 million, 400,000 of them being caused by tuberculo-
sis [1].
In Brazil, the southern region has the highest percentage of co-infection in the country
(18.2%), almost twice the national average [12,13]. Porto Alegre is the state capital with the
highest incidence of HIV/AIDS and the second highest incidence of tuberculosis. The city has
the largest proportion of co-infected people in Brazil, with 25% of the tuberculosis cases occur-
ring in people living with HIV. These indicators show the striking impact of the disease in
Porto Alegre as compared to other Brazilian cities [12,13].
Many strategies have been discussed to prevent hospitalization and death in locations
pointed out by the World Health Organization as having a great burden of tuberculosis and
HIV infection [1,2,13–15]. In this regard, Brazil is considered a pioneer since its adoption in
1996 of antiretroviral therapy for all people living with HIV, regardless of CD4 count [16].
Moreover, the Global Fund to Fight AIDS, Tuberculosis and Malaria has been increasing its
actions to reduce TB/HIV co-infection by expanding the Directly Observed Treatment Short-
Course (DOTS) strategy in large urban centers such as Porto Alegre [17] with a high tubercu-
losis burden [1,2].
Brazil is among the top 20 countries worldwide with the highest incidence of TB/HIV co-
infection, with 13 cases per 100,000 inhabitants. The most affected countries are on the African
continent with rates of up to 72 cases per 100,000 inhabitants [1]. Studies show that the occur-
rence of hospitalization and death in co-infected patients is considerably high [3,5,7,8,18–20].
In Ethiopia, for example, mortality in patients with co-infection reaches 20.2% [8]. In Camer-
oon, a cohort recruited during eight years showed a proportion of almost 30% of deaths in hos-
pitalized co-infected patients [18]. This situation implies high social and financial costs for
public health systems, especially in Brazil, where the system is universal and totally free [1].
Given the importance and scale of the problem, a study was designed to analyze the risk factors
for hospitalization and death in cases of TB/HIV co-infection in Porto Alegre.
Materials and methods
This is a population-based, retrospective cohort study that consisted of the analysis of all cases
of pulmonary tuberculosis and HIV co-infection among residents of the city of Porto Alegre
from 2009 to 2013.
We used the following sources of information: cases of tuberculosis and AIDS registered in
the Brazilian Information System for Notifiable Diseases (SINAN) over a period of five years
Risk factors for hospitalization and death in TB/HIV co-infected persons
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(2009–2013); hospitalizations recorded in the Hospital Information System (SIH) over a
period of three years after the diagnosis of each patient; and deaths recorded in the Mortality
Information System (SIM) over a period of two years. This follow-up period was defined in
the methodology of the study, taking into account the time to update the national systems
used (SIM and SIH). The hospitalization data were collected until 2016, although the cohort
was from 2009 to 2013, aiming at the same follow-up period for all. For example, patients who
entered the cohort in 2013 were followed up until 2016 (with a 3-year follow-up). The mortal-
ity system is updated every 2 years, so mortality data for 2016 are being entered into the system
in 2018. In order to be able to complete 3 years of following up the mortality of the new
patients in 2013, we would have to access data for 2016, which will be made available in the sys-
tem this year, 2018. Thus, in order to achieve a 2-year follow-up on mortality for patients who
entered in 2013 (follow-up until 2015), the data until December 2017 were accessed. These
data were available on the national systems at the end of the study. Only hospitalizations and
deaths related to TB/HIV were considered. Tuberculosis/HIV/AIDS co-infection was defined
as every case reported as pulmonary tuberculosis in SINAN-TB that had a confirmed AIDS or
HIV positive test. Subsequently, all cases with tuberculosis that had an anti-HIV test with neg-
ative or in progress results were checked in the SINAN-AIDS database to confirm co-
infection.
After a single database using SINAN data was created, SIH and SIM were respectively
checked for hospitalizations and deaths. The linkage between SINAN, SIH and SIM databases
included the individual’s full name, date of birth and mother’s name. The data available in
SINAN, which is a mandatory notification system, is registered at the time of TB/HIV diagno-
sis and used for the investigation of hospitalizations and mortality.
As far as the organization of health care services and resources is concerned, the city of
Porto Alegre is divided into eight district health authorities (DHAs): Centro (CEN), Baltazar
(NEB), East/Northeast (LENO), Gloria/Cruzeiro/Cristal (GCC), South/Center South (SCS),
Parthenon/Lomba do Pinheiro (PLP), Restinga/South End (RES), Northwest/Humaita´/Nave-
gantes/Ilhas (NHNI). This geographical division was used to analyze the place of origin of the
cases. The reference category for the RR analysis was defined after the proportions of the hos-
pitalization and death events were assessed at the respective locations. We chose the location
with the lowest hospitalization and death rates as the reference category for this variable.
Sociodemographic and epidemiological variables were also investigated. The former
included place of origin (DHA), age, gender, race/ethnicity and education; the latter, type of
entry in SINAN, prescription of directly observed therapy (DOT) and status at completion.
The type of entry was classified into new case (never treated), relapse (patient cured and
infected once again by tuberculosis), return after default (patient who interrupted the treat-
ment and is about to resume it) or transfer (when the individual was being treated at another
health facility and was transferred). The new case category was defined as the reference cate-
gory for analysis. The variable status at completion refers to what happened after the tuberculo-
sis treatment was monitored by the national surveillance system, that is: cure, default,
transference, death or multiresistance. In this variable, the category cure was defined as the ref-
erence category.
We performed the analysis using two softwares: Statistical Package for the Social Sciences
(SPSS), version 18.0, and R, version 3.2.0. The chi-square test of Person and the Fisher’s exact
test were used to compare groups in relation to outcomes, whereas the T-student test was used
for independent samples. Measures of association for each category of the exploratory vari-
ables were estimated through regression models, with reference to the lowest expected risk cat-
egory. Predictor variables were included in the regression models based on theoretical
knowledge of the outcomes through univariate models. For the multi-variable model, those
Risk factors for hospitalization and death in TB/HIV co-infected persons
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variables with clinical importance or with a p-value less than 0.25 were included. The multivar-
iable model estimated the associations for each exploratory variable in a regression model that
simultaneously included all variables, in order to examine the independent effect of each
exploratory variable on the outcome. For crude and adjusted measures of association, the
Wald test was used. The significance of 5% was adopted to determine whether the variable was
associated with the outcome in the multi-variable model. RR values, p value and 95% confi-
dence interval values were used for the modeling of each outcome,
This study complied with the guidelines of the Resolution 466/2012 of the Brazilian
National Health Council. The research project was approved by the Ethics and Research Com-
mittee of the Federal University of Rio Grande do Sul (UFRGS) and by the Ethics Committee
of the Municipal Government of Porto Alegre, opinions 952907 and 939250, respectively.
Since this is a linkage study of national databases, patients needed to be identified for the link-
age procedure to succeed. This was informed in the research protocol to the ethics committee,
which approved the study waiving the need for a term of consent.
Results
There were 2,419 cases of TB/HIV co-infection in Porto Alegre, of which 63.1% were hospital-
ised and 27.4% died in the period studied.
Table 1 shows the sociodemographic, epidemiological and clinical characteristics of the co-
infected patients in Porto Alegre, according to the occurrences of hospitalization and death.
The factors significantly associated with hospitalization were: DHA, schooling, entry situation
and implementation of DOT. The factors significantly associated with death were schooling,
age, DOT recommendation and implementation of DOT.
Table 2 presents the risk factors for the occurrence of hospitalization in cases of TB/HIV co-
infection in Porto Alegre. In the crude regression model, the linearity of the variable year was veri-
fied, and it was observed that, for each year, the risk of hospitalization increased 7% (RR = 1.07;
CI 95%: 1.01–1.14). The variable education was predictive for the occurrence of hospitalization
(p<0.001). As to the place of origin, the proportion of hospitalizations was lower in PLP, and
therefore this was considered a reference category. Compared to this category, the other DHAs
showed a positive association with the outcome. In terms of the type of entry registered in
SINAN, relapse cases had 1.36 times more risk of hospitalization (RR = 1.36; CI 95%: 1.06–1.74);
the cases of return after default, 1.65 times more risk (RR = 1.65, CI 95%: 1.34–2.02); and transfer
was not significant. Considering the completion status registered in SINAN, default cases had
1.65 times more risk of hospitalization (RR = 1.65; CI 95%: 1.36–2.01) and multidrug-resistant TB
(MDR), 4.89 times more risk (RR = 4.89; CI 95%: 2.52–10.8). Transfer was not associated with the
outcome.
In the regression model adjusted for the hospitalization outcome (Table 2), the variables show-
ing a positive association with the outcome were as follows: education less than or equal to 7 years
(RR = 3.47, CI 95%: 1.97–6.29); education from 8 to 11 years (RR = 2.56, CI 95%: 1.44–4.69);
DHA CEN (RR = 1.4, 95% CI: 1.05–1.87); DHA GCC (RR = 1.42, CI 95%: 1.03–1.96); entry in
SINAN, where return after default presented 1.35 times more risk of hospitalization (RR = 1.35,
CI 95%: 1.07–1.7); and status at completion, whose categories default (RR = 1.47, CI 95%: 1.18–
1.83), death (RR = 1.94, CI 95%: 1.5–2.51) and MDR-TB (RR = 3.94, CI 95%: 1.97–8.81) presented
positive association with the outcome.
Table 3 presents the risk factors for death in cases of TB/HIV co-infection in Porto Alegre.
In the crude regression model for the mortality outcome, the linearity of the year and age vari-
ables were verified, and it was observed that, for each year of the analyzed period, the risk of
death decreased by 10% (RR = 0.91, CI 95% 0.85–0.97). Meanwhile, for every additional year
Risk factors for hospitalization and death in TB/HIV co-infected persons
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in the age of notification, the risk of death increased by 3% (RR = 1.03, CI 95%: 1.01–1.04).
Nevertheless, these variables were not associated with the outcome in the multivariable model.
Level of education proved to be associated with mortality. As to the place of origin, the propor-
tion of deaths was lower in PLP, and therefore this was considered a reference category. Con-
cerning SINAN type of entry, new case was used as a reference category, and there was no
statistical differences in the other categories, except for transfer, which showed a negative asso-
ciation with the mortality outcome (RR = 0.41, CI 95%: 0.17–0.85). Cases without prescription
Table 1. Socio-demographic, epidemiological and clinical characteristics of TB/HIV co-infected persons according to the occurrence of hospitalization and death
in Porto Alegre, Brazil, from 2009 to 2013.
Characteristics Total Hospitalization p-value Death p-value
DHA
�
<0.001c 0.462c
CEN 430 (17.8%) 274 (63.7%) 111 (25.8%)
NHNI 159 (6.6%) 99 (62.3%) 48 (30.2%)
NEB 264 (10.9%) 186 (70.5%) 74 (28%)
LENO 380 (15.7%) 239 (62.9%) 106 (28%)
GCC 286 (11.8%) 193 (67.5%) 82 (28,7%)
SCS 170 (7%) 117 (68.8%) 50 (29.4%)
PLP 557 (23%) 309 (55.5%) 135 (24.3%)
RES 171 (7.1%) 108 (63.2%) 55 (32.4%)
Race/ethnicity 0.097c 0.978a
White 1357 (56.3%) 838 (61.8%) 371 (27.4%)
Nonwhite 1054 (43.7%) 686 (65.2%) 288 (27.4%)
Gender 0.965a 0.564a
Male 1588 (65.6%) 1003 (63.2%) 441 (27.8%)
Female 831 (34.4%) 524 (63.1%) 221 (26.7%)
Years of education completed <0.001c 0.013c
�7 years 1548 (69.2%) 1027 (66.3%) 433 (28%)
From 8 to 11 years 629 (28.1%) 366 (58.2%) 151 (24.1%)
�12 years 59 (2.6%) 19 (32.2%) 8 (13.6%)
Age 38 ± 9.91 37.88 ± 9.93 0.422b 39.93 ±10.7 < 0.001b
Type of entry <0.001c 0.068c
New case 1389 (57.4%) 825 (59.4%) 378 (27.3%)
Relapse 351 (14.5%) 233 (66.4%) 100 (28.5%)
Return after default 622 (25.7%) 438 (70.4%) 177 (28.5%)
Transfer 57 (2.4%) 31 (54.4%) 7 (12.3%)
Prescription of DOT
��
0.532a <0.001a
Yes 627 (26%) 389 (62%) 122 (19.5%)
No 1785 (74%) 1133 (63.5%) 538 (30.2%)
DOT
��
completed 0.037a <0.001a
Yes 406 (16.9%) 275 (67.7%) 74 (18.3%)
No 1994 (83.1%) 1240 (62.2%) 581 (29.2%)
Total 2.419 (100%) 1.527 (63.1%) 662 (27.4%)
ap-value associated with Fisher’s exact test
bp-value associated with the T-test for independent samples
cTest of homogeneity of proportions based on Pearson’s chi-square test
�District Health Authorities (DHA): Centro (CEN), Baltazar (NEB), East/Northeast (LENO), Gloria/Cruzeiro/Cristal (GCC), South/Center South (SCS), Parthenon/
Lomba do Pinheiro (PLP), Restinga/South End (RES), Northwest/Humaita´/Navegantes/Ilhas (NHNI)
��DOT = Directly observed therapy.
https://doi.org/10.1371/journal.pone.0209174.t001
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of DOT showed 1.77 times more risk of death than those with it (RR = 1.77, CI 95%: 1.42–
2.22).
Table 2. Risk factors for hospitalization in cases of TB/ HIV co-infection in Porto Alegre, from 2009 to 2013.
Characteristics Crude RR (CI 95%)a Adjusted RR (CI 95%)b
Year 1.07 (1.01–1.14)� 1.06 (0.99–1.13)
Gender p = 0.937 p = 0.434
Male Reference Reference
Female 1.01 (0,85–1.2) 0.93 (0.76–1.12)
Age 1.00 (0.99–1)�� 1 (0.99–1.01)
Years of education completed p<0.001 p<0.001
�7 4.14 (2.41–7,38) 3.47 (1.97–6.29)
8–11 2.93 (1.68–5.28) 2.56 (1.44–4.69)
� 12 Reference Reference
Race ∕ethnicity (self-declared) p = 0.120 p = 0.475
White Reference Reference
Others 1.14 (0.97–1.35) 1.07 (0.89–1.29)
DHAc p = 0.001 p<0.001
CEN 1.40 (1.08–1.81) 1.4 (1.05–1.87)
GCC 1.67 (1.24–2.26) 1.42 (1.03–1.96)
LENO 1.35 (1.04–1.77) 1.23 (0.91–1.65)
NHNI 1.35 (0.94–1.95) 2.01 (1.44–2.82)
NEB 1.93 (1.42–2.66) 1.43 (0.97–2.13)
PLP Reference Reference
RES 1.38 (0.97–1.97) 1.31 (0.9–1.92)
SCS 1.78 (1.24–2.57) 1.95 (1.32–2.92)
Type of entry p<0.001 p<0.001
New case Reference Reference
Relapse 1.36 (1.06–1.74) 1.26 (0.97–1.65)
Return after default 1.65 (1.34–2.02) 1.35 (1.07–1.7)
Transfer 0.71 (0.41–1.24) 0.67 (0.35–1.25)
Status at completion p<0.001 p<0.001
Cure Reference Reference
Default 1.65 (1.36–2.01) 1.47 (1.18–1.83)
MDR-TBd 4.89 (2.52–10.8) 3.94 (1.97–8.81)
Transfer 0.71 (0.45–1.11) 0.74 (0.46–1.19)
Prescription of DOTe p = 0.478 p = 0.197
Yes Reference Reference
No 1.07 (0.89–1.29) 0.87 (0.7–1.08)
aunivariate models
bmulti-variable model by the logistic regression method
�p-value <0,05
��p-value = 0,455
cDistrict Health Authorities (DHA): Centro (CEN), Baltazar (NEB), East/Northeast (LENO), Gloria/Cruzeiro/Cristal
(GCC), South/Center South (SCS), Parthenon/Lomba do Pinheiro (PLP), Restinga/South End (RES), Northwest/
Humaita´/Navegantes/Ilhas (NHNI)
dMDR-TB = Multidrug-resistant TB
eDOT = Directly observed therapy.
https://doi.org/10.1371/journal.pone.0209174.t002
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In the regression model adjusted for the mortality outcome (Table 3), the following vari-
ables showed association with the outcome: education, in which categories up to 7 years
(RR = 3.94, CI 95%: 2.26–7.09) and 8 to 11 years (RR = 2.84, CI 95%: 1.61–5.16) presented risk
of mortality; place of origin, whose categories CEN (RR = 1.54, CI 95%: 1.17–2.05), GCC
(RR = 1.59, CI 95%: 1.16–2.18), LENO (RR = 1.37, CI 95%: 1.03–1.84), NHNI (RR = 1.53, CI
95%: 1.04–2.26), NEB (RR = 2.05, CI 95% 1.48–2.86) and SCS (RR = 2.04, CI 95%: 1.39–3.05)
presented risk of mortality; and SINAN type of entry, where category return after default
Table 3. Risk factors for mortality in cases of TB/HIV co-infection in Porto Alegre, from 2009 to 2013.
Characteristics Crude RR (CI 95%)a Adjusted RR (CI 95%)b
Year 0.91 (0.85–0.97)�� 1.07 (1.01–1.14)�
Gender p = 0.564 p = 0.675
Male Reference Reference
Female 1.06 (0.87–1.28) 0.96 (0.79–1.16)
Age 1.03 (1.01–1.04)��� 1 (0.99–1.01)
Years of Education p = 0.008 p<0.001
�7 2.49 (1.24–5.71) 3.94 (2.26–7.09)
8–11 2.02 (0.99–4.69) 2.84 (1.61–5.16)
� 12 Reference Reference
Race ∕ethnicity (self-declared) p = 0.996 p = 0.477
White Reference Reference
Others 1.00 (0.83–1.,2) 1.07 (0.89–1.29)
DHAc p = 0.501 p<0.001
CEN 1.09 (0.81–1.46) 1.54 (1.17–2.05)
GCC 1.25 (0.9–1.72) 1.59 (1.16–2.18)
LENO 1.2 (0.89–1.61) 1.37 (1.03–1.84)
NHNI 1.35 (0.91–1.99) 1.53 (1.04–2.26)
NEB 1.22 (0.87–1.7) 2.05 (1.48–2.86)
PLP Reference Reference
RES 1.47 (1.01–2.13) 1.39 (0.96–2.03)
SCS 1.29 (0.88–1.89) 2.04 (1.39–3.05)
Type of entry p = 0.07 p<0.001
New case Reference Reference
Relapse 1.08 (0.83–1.39) 1.33 (1.03–1.73)
Return after default 1.08 (0.87–1.33) 1.53 (1.22–1.91)
Transfer 0.41 (0.17–0.85) 0.66 (0.36–1.23)
Prescription of DOTd p<0.001 p = 0.085
Yes Reference Reference
No 1.77 (1.42–2.22) 0.83 (0.68–1.03)
aunivariate models
bmulti-variable model by the logistic regression method
�p-value <0.05
��p-value <0.01
���p-value <0.001
cDistrict Health Authorities (DHA): Centro (CEN), Baltazar (NEB), East/Northeast (LENO), Gloria/Cruzeiro/Cristal
(GCC), South/Center South (SCS), Parthenon/Lomba do Pinheiro (PLP), Restinga/South End (RES), Northwest/
Humaita´/Navegantes/Ilhas (NHNI)
dDOT = Directly observed therapy.
https://doi.org/10.1371/journal.pone.0209174.t003
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presented 1.53 times more risk of mortality than the reference category (RR = 1.53, CI 95%:
1.22–1.91).
Discussion
This study shows that more than 60% of TB/HIV co-infection cases resulted in at least one
hospitalization and that nearly 30% of the patients died. Our mortality data over a five-year
period is similar to that of an eight-year cohort conducted in Cameroon with hospitalized
patients, where 29% died [18]. In another study carried out in Ethiopia, 7.6% out of 158 co-
infected patients under outpatient treatment died [19]. The vulnerability of co-infected indi-
viduals to opportunistic infections may explain the high occurrence of such outcomes
[3,19,21], especially in a location with high default rates [3,22,23] such as Porto Alegre [12,13].
Against this background, the importance of the adherence to the tuberculosis treatment [24–
26] has been highlighted in health care policies, since it prevents multidrug resistance and
eventually leads to cure. Adherence to treatment also prevents new opportunistic infections in
people living with HIV [1].
Regarding sociodemographic characteristics, this study confirmed the results of previous
research [27,28]. The profile of the co-infected individual is a white males with a low level of
education and a mean age of 38 ± 9,91 years. The risk of death was higher for every additional
year of age at the time of the notification of co-infection (p<0.05), and this may indicate the
probability of death due to late diagnosis in a scenario with a growing number of cases of co-
infection [29]. The effect of calendar time for hospitalisation was very close to significance. An
explanatory hypothesis for this finding is the fragility of specialized services in ensuring con-
tinued care to promote adherence to treatment in a scenario with the highest prevalence of TB
and the highest rate of AIDS detection in the country. It may also be related to difficulties in
accessing health services, as seen in other studies [30,31], despite the free availability of medi-
cation for tuberculosis and AIDS in Brazil [2]. Another weakness in the Brazilian health system
is the difficulty of identifying the initial symptoms of TB, which makes it impossible to diag-
nose the disease in patients living with HIV [30].
Co-infection has a great social impact. Most of the patients are economically active and gen-
erally provide for their families, contributing to the social and economic development of their
communities [18,32]. The social costs of the illness result also from the need for long-term fol-
low-up and treatment [33]. Failure in access and adherence, added to difficulties related to the
treatment, often culminate in neglect, relapses, frequent hospitalizations and high mortality
rates [29,34,35].
In the sample studied, a low level of education was identified as a risk factor for hospitaliza-
tion (p<0.001) and death (p<0.001). The proportion of co-infected patients with a low level of
education was higher than that found in other Brazilian studies [36,37], pointing to a different
profile in the city of Porto Alegre. In the national systems used in this study, income informa-
tion was not available, and so the level of education was used as a proxy for socioeconomic sta-
tus and was significantly associated with the outcomes. In fact, it was observed that the lower
the level of education, the higher the risk both for hospitalization and mortality. Studies have
suggested that individuals with poor education may postpone the demand for health services
or find barriers to accessing it. Consequently, they find it difficult to receive diagnosis and
treatment [28,38], a process leading to hospitalization and death.
Co-infection cases with the highest risk of hospitalization (p<0.001) and death (p<0.001)
belonged to DHAs of extreme social vulnerability [39,40]. Other studies also related the highest
occurrence of tuberculosis, HIV, and death due to tuberculosis to locations distinguished by
their severe poverty [23,41,42]. People with lower income and education are more vulnerable
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to therapeutic failure and poor adherence to treatment [9,19]. A recent qualitative study con-
ducted in the same setting [8] showed that social vulnerability is related to hospitalization for
tuberculosis. Regarding the type of entry in the surveillance system, cases registered as return
after treatment default were 35% more likely to be hospitalized and 53% more likely to die
than new cases (p<0.001). Likewise, relapses were 26% more likely to be hospitalized and 33%
more likely to die than new cases (p<0.001). With regard to treatment default, it must be
noted that adherence to treatment is one of the most important topics in the public policy
agenda in view of the difficulty to manage the double burden of diseases [43]. In fact, several
studies have emphasized the benefits of the early initiation of treatment for patients recently
diagnosed with HIV [18,19,44,45].
The proportion of cases found in the category return after default highlights the need to qualify
the current actions concerning adherence to treatment in Brazil. This is all the more important as
treatment discontinuation can significantly impact the occurrence of multidrug-resistant tubercu-
losis [46,47]. The cases of multidrug-resistant tuberculosis presented a risk of hospitalization 3.94
times higher than new cases (p<0.001). Multidrug-resistant tuberculosis has been associated with
a higher exposure to opportunistic diseases and increased mortality [20,41,44,48].
In this study, the transfer of the patient to another health care service was not maintained
in the multivariable model of the outcomes. Transfer situations usually occur when individuals
leave the Rio Grande do Sul state capital of Porto Alegre for towards cities in the hinterland.
This fact probably indicates the quality and pro-activity of small city and town health services
compared to those of Porto Alegre. Currently, Porto Alegre provides public health services for
a population of approximately 1,500,000 residents and is a reference center for the care of
more than 3 million people in the municipalities of the metropolitan region.
Directly observed therapy (DOT) [1], although used worldwide [49–51], did not stand out
as a therapeutic approach in the cases studied. Although it was indicated for almost 30% of the
cases, it was performed only in 16.9%. In spite of this difference, DOT was not associated with
the outcomes in the adjusted models. Patients who entered the surveillance system in the cate-
gory return after default presented a higher risk of hospitalization and mortality, showing the
direct influence of non-adherence to treatment. These patients benefitted from DOT. How-
ever, in Porto Alegre, primary care services have yet not sufficiently incorporated this technol-
ogy [52]. Our study has certain limitations. It did not include in its analysis information about
treatment regimens or CD4 counts, once they were not stored in the accessed databases. We
used schooling as a proxy of socioeconomic level as there was no available information on dis-
posable income, and the use of education in place of socio-economic status might fail to prop-
erly discriminate between rich and poor. Therefore, further studies on the management and
adherence of co-infected patients are strongly recommended. Additional research on hospital
admissions can also contribute to the management of co-infected patients in Porto Alegre.
This is all the more important as death from tuberculosis is often the last stage of a health-dis-
ease process that could well be avoided.
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